Proteasome and HDAC inhibitors interact strongly to promote cell death in multiple myeloma and other human cancer cells. This study challenges current assumptions about the mechanisms underlying these interactions.
|Original language||English (US)|
|Number of pages||2|
|State||Published - Jul 22 2010|
ASJC Scopus subject areas
- Cell Biology